Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer
- 24 May 2010
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 18 (14), 5352-5366
- https://doi.org/10.1016/j.bmc.2010.05.042
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P01 CA48112)
- National Institutes of Health (C06-14499)
- China Scholarship Council
- Dr. Hongxiang Lou (Shandong University, PR China)
This publication has 63 references indexed in Scilit:
- Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory ActivitiesJournal of Medicinal Chemistry, 2009
- Structural basis for androgen specificity and oestrogen synthesis in human aromataseNature, 2009
- Second-Generation DBFOX Ligands for the Synthesis of β-Substituted α-Amino Acids via Enantioselective Radical Conjugate AdditionsThe Journal of Organic Chemistry, 2008
- Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2Biochemical Journal, 2008
- Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factorBritish Journal of Cancer, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- Improved protein–ligand docking using GOLDProteins-Structure Function and Bioinformatics, 2003
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D-Biological Crystallography, 1994